Is this true? Or just appears to be?
. . . Of course the holy money speaks first! ! !
This fierce war had to have an explanation.

https://www.dn.pt/mundo/fuga-de-informacao-pfizer-cobra-12-euros-a-ue-por-cada-dose-de-vacina-13154969.html

IS ASTRAZENECA DANGEROUS?

This is the question that is constantly being asked and that has come to discredit the vaccine, which in fact is very dangerous for the pharmaceutical industry. The big problem is not its danger to our health, but its costs, which are much lower than those of the competition.
Eva De Bleeker, Secretary of State for the Belgian Budget, committed the distrust of revealing the amounts that the European Union is paying for the unit cost of each of the different vaccines. She published the following cost table on her social networks:
Astrzeneca – 1,78 € (each vaccine)
Modern – 14,7€ (8.25 times more)
Pfizer – 12€ (6.74 times more)
Cure Vac – 10€ (5.61 times more)
Sanofi / GSK – 7.56€ (4.24 times more)
Janssen – 6.90 € (3.87 times more)
As expected, there was an immediate protest from several laboratories who claimed that the “confidentiality clause” of the contract established with the EU was not respected.
Eva De Bleeker hastened to erase what she had published, but it was too late, her writing had already been copied and widely circulated.
Then came a huge campaign to discredit the vaccine that committed the heresy of being much cheaper.
The campaign lasts… It lasts and will continue to last, until most countries stop using it or only use it in increasingly restricted groups.
It should be remembered that Astrazeneca was developed following procedures, which have been tested for a long time, and are followed in the common anti-flu vaccines that are modified every year to adapt to the new strains that appear. A fragment of the virus that has antigenic power (it generates the production of antibodies that will fight a future infection) has no pathogenic power (it does not cause the disease) is injected.
Other vaccines used new, untried technologies, some based on mRNA. And that they had, obviously, higher production costs but that do not justify the huge price difference.

Let’s wait for the scenes in the next chapters.